Keysight Technologies, Inc. (BMV:KEYS)

Ligand Pharmaceuticals Revenue

Keysight Technologies had revenue of $1.31B USD in the quarter ending April 30, 2025, with 7.40% growth. This brings the company's revenue in the last twelve months to $5.11B, down -1.16% year-over-year. In the fiscal year ending October 31, 2024, Keysight Technologies had annual revenue of $4.98B, down -8.88%.

• Revenue (ttm): $5.11B
• Revenue Growth: -1.16%
• P/S Ratio: 5.16
• Revenue / Employee: $329.55K
• Employees: 15,500
• Market Cap: 516.77B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2024	4.98B	-485.00M	-8.88%
Oct 31, 2023	5.46B	44.00M	0.81%
Oct 31, 2022	5.42B	479.00M	9.69%
Oct 31, 2021	4.94B	720.00M	17.06%
Oct 31, 2020	4.22B	-82.00M	-1.91%